Crossmark

Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma

Published Online: 2019-03-26

Published Print: 2019-12

Authors

Ladanyi, Marc

Sanchez Vega, Francisco

Zauderer, Marjorie
Funding

Funding for this research was provided by:

U.S. Department of Defense
License Information

Text and Data Mining valid from 2019-03-26

Version of Record valid from 2019-03-26
More Information

Article History

First Online: 26 March 2019

Competing interests

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current